Phase IV Efficacy Study of MMR Vaccine in Preventing or Reduction of Severity of COVID-19 in Healthcare Workers Adults : Phase IV Clinical Efficacy Study, randomized, double-blind, placebo controlled MMR Vaccine (against measles, mumps and rubella) in the Prevention or Reduction of Severety of COVID-19 in Men and Women Healthcare Workers 18 to 60 years old

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Population at Risk; Coronavirus Infection
Recruitment Status: Recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 12-02-2021, Last updated: 2023-06-05

ICTRP ID:

RBR-2xd6dkj

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007531958